Skip to main content

Table 4 Microbiological diagnosis

From: Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study

Microbiological diagnosis, n [patients with a positive microbiological diagnosis] (%)

Early responders n = 332

Later responders n = 253

Patients without Halm-based assessment of TCS n = 1454

Number of patients with a microbiological diagnosis

87 (26.2)

87 (34.4)

408 (28.1)

Gram-positive cocci*

40 (46.0)

38 (43.7)

208 (51.0)

Streptococcus pneumoniae

32 (36.8)

28 (32.2)

168 (41.2)

 Penicillin-resistant Streptococcus pneumoniae

0

1 (1.1)

1 (0.2)

 Methicillin-resistant Staphylococcus aureus

0

1 (1.1)

11 (2.7)

 Methicillin-susceptible Staphylococcus aureus

9 (10.3)

9 (10.3)

33 (8.1)

Legionella spp.

4 (4.6)

3 (3.4)

13 (3.2)

Mycoplasma pneumoniae

4 (4.6)

1 (1.1)

13 (3.2)

Chlamydophila pneumoniae

0

2 (2.3)

11 (2.7)

Gram-negative bacilli

15 (17.2)

11 (12.6)

81 (19.8)

Haemophilus influenzae

7 (8.0)

3 (3.4)

23 (5.6)

Haemophilus parainfluenzae

3 (3.4)

1 (1.1)

2 (0.5)

Moraxella catarrhalis

2 (2.3)

0

7 (1.7)

Pseudomonas aeruginosa

4 (4.6)

8 (9.2)

29 (7.1)

Escherichia coli

4 (4.6)

3 (1.4)

29 (7.1)

Klebsiella spp.

2 (2.3)

0

17 (4.2)

Aspiration pneumonia§

1 (1.1)

4 (4.6)

12 (2.9)

Other microorganisms

19 (21.8)

32 (36.8)

82 (20.1)

Unknown (not identified)

248 (74.7)

167 (66.0)

1060 (72.9)

  1. *Includes other Streptococcus spp. and Staphylococcus spp.
  2. Includes Morganella morganii, Pasteurella multocida, Proteus mirabilis and Serratia marcescens, Acinetobacter spp. and Hafnia alvei.
  3. §Commonly applied to situations when a patient with risk factors for aspiration presents with pneumonia.